Take part in a paid clinical trial

At Nucleus Network, we take the time to understand you and your health history, so we can match you with clinical trials that truly fit.

Search trials

Expression of Interest

Current clinical trials

The Hair Trial

MEL | Currently Recruiting

This study is testing a potential new treatment aimed at slowing, stopping, or even reversing hair loss. By taking part, you’ll contribute directly to hair loss research while receiving expert medical care and guidance throughout the process. Participants are closely supported at every step, with regular check-ins and access to our study team for any questions. Your involvement could help improve treatments for people experiencing hair thinning or balding.

This study is designed for healthy volunteers and is not specifically targeting individuals with a diagnosed hair loss condition, although having some hair thinning does not automatically exclude you.

Requirements

Female, Female (Post-menopausal) or Female of non-childbearing potential
Healthy
18 - 65 years old
BMI 18 - 32 kg/m²
Not taking any medications
Non-smoker or Occasional smoker

Start dates

17 Aug 2026

Study visits

Appointment only, 22 clinic visits

Remuneration

Up to $21,860

22 clinic visits

Learn more about the Hair Trial Apply

The Indigo Study

MEL | Currently Recruiting

This study is looking at an investigational oral drug for people living with obesity or overweight.

Obesity is a chronic disease that is estimated to affect ~880 million adults globally. Adults living with obesity and overweight are at higher risk for other health problems. For some people, medicines are recommended to support weight management; however, more treatment options are needed to treat this chronic disease.

The investigational drug is an oral tablet that is designed to help people feel full sooner and reduce feelings of hunger, which may help people eat less over time.

Requirements

Male or Female
Healthy
18 - 60 years old
BMI 25 - 35 kg/m²
Non-smoker or Occasional smoker

Start dates

29 Jul 2026

Study visits

Up to 4 nights, 5 clinic visits

Remuneration

Up to $4,200

Up to 4 nights
5 clinic visits

Learn more about the Indigo Study Apply

The Align Study

MEL | Currently Recruiting

This study is exploring a potential new medication which has been developed to target a protein called HER2. HER2 plays an important role in the growth of some types of cancer. In some cancers, changes in HER2 causes cells to grow and divide more than they should.

While there are other treatments available which target HER2, some become less effective over time or do not reach all areas of the body, such as the brain.

This study is evaluating a potential treatment designed to target HER2 precisely. It is hoped to help overcome some of the limitations which current treatments face.

Requirements

Male, Female, Female (Post-menopausal) or Female of non-childbearing potential
Healthy
18 - 65 years old
BMI 18 - 32 kg/m²
Not taking any medications
Non-smoker or Occasional smoker

Start dates

26 Jul 2026

Study visits

12 nights, 7 clinic visits

Remuneration

Up to $8,860

12 nights
7 clinic visits

Learn more about the Align Study Apply

The Explore Study

MEL | Currently Recruiting

This pre-screening study is part of the enrolment process for an upcoming clinical research study. Taking part in this screening study allows researchers to assess your eligibility for participation.

The study is in relation to Epstein–Barr virus (EBV) is a very common virus that infects more than 9 out of 10 adults worldwide. It is best known for causing infectious mononucleosis, sometimes called “glandular fever or mono”, particularly when infection occurs during the teenage years or early adulthood.

EBV has also been linked to certain cancers, autoimmune conditions, and multiple sclerosis.

Once a person is infected, EBV remains in the body for life. The virus usually stays inactive (dormant), but it can reactivate from time to time, often without causing symptoms.

The study vaccine uses mRNA technology, which has been widely used and studied in COVID‑19 vaccines. mRNA vaccines provide instructions to the body that help the immune system recognise and fight a virus. The mRNA does not contain live virus and does not remain in the body.

The start date for this study is flexible. If you pass the initial screening, the study coordinator will work with you to schedule your exact dates.
Please note that you can only be admitted between Sunday and Thursday.

Requirements

Male or Female
Healthy
18 - 25 years old
BMI 18 - 40 kg/m²
Not taking any medications
Non-smoker, Occasional smoker or Heavy smoker

Study visits

Appointment only, 1 clinic visit

Remuneration

Up to $200

1 clinic visit

Learn more about the Explore Study Apply

The Alzheimer's Forward Study

MEL | Currently Recruiting

This clinical study is investigating a potential new treatment for Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia worldwide and affects memory, thinking, and the ability to carry out everyday activities.

Over time, an abnormal protein builds up develop in the brain, which damage nerve cells and lead to worsening symptoms. Alzheimer’s disease places a growing burden on individuals, families, and healthcare systems.

While some medicines are currently approved that can help slow the progression of the disease, there is still a strong need for further research into new and improved treatments.

The study medicine is a laboratory‑made antibody designed to attach to a protein linked to Alzheimer’s disease. It is designed to enter the brain more easily, which may allow it to work at lower doses and reduce some brain‑related side effects.

Requirements

Male or Female
Healthy
18 - 54 years old
BMI 18 - 32 kg/m²
Not taking any medications
Non-smoker or Occasional smoker

Start dates

26 Jul 2026

Study visits

11 nights, 6 clinic visits

Remuneration

Up to $9,530

11 nights
6 clinic visits

Learn more about the Alzheimer's Forward Study Apply

The Sustainable Health Study

BNE | Currently Recruiting

We are conducting a clinical trial to explore a potential new treatment for weight management and metabolic disorders. This treatment is being developed to support healthy weight loss while helping the body maintain lean muscle mass, which plays an important role in long-term weight maintenance. Through this study, we hope to better understand whether this new approach can provide a safe and effective option for people who may benefit from additional support with managing their weight. By joining the trial, you’ll be contributing to important research that could help improve weight management options in the future.

Requirements

Female (Post-menopausal) or Female of non-childbearing potential
Healthy
45 - 75 years old
BMI 20 - 40 kg/m²
Non-smoker, Occasional smoker or Heavy smoker

Start dates

23 Jul 2026

Study visits

7 nights, 9 clinic visits

Remuneration

Up to $10,070

7 nights
9 clinic visits

Learn more about the Sustainable Health Study Apply

The Headline Trial

MEL | Currently Recruiting

We’re currently looking for adults aged 18 to 65 who are experiencing androgenetic alopecia (AGA), also known as pattern hair loss, to take part in The Headline Trial.

Hair loss is common and can affect both men and women. This clinical study is investigating new approaches that may help shape future treatment options.

You don’t need a formal diagnosis to get started. If you think you may have AGA, you can begin with a quick pre-screen. This helps us assess whether you may meet the initial study requirements. Completing the pre-screen doesn’t guarantee enrolment, but it’s an important first step in seeing whether the study may be suitable for you.

By getting involved, you’ll be contributing to research that aims to improve future options for people affected by hair loss.

Requirements

Male
Healthy
18 - 65 years old
BMI 18 - 32 kg/m²
Not taking any medications

Study visits

12 nights, 20 clinic visits

Remuneration

Up to $27,460

12 nights
20 clinic visits

Learn more about the Headline Trial Apply

The Explore Study

BNE | Currently Recruiting

This pre-screening study is part of the enrolment process for an upcoming clinical research study. Taking part in this screening study allows researchers to assess your eligibility for participation.

EBV has also been linked to certain cancers, autoimmune conditions, and multiple sclerosis.

Once a person is infected, EBV remains in the body for life. The virus usually stays inactive (dormant), but it can reactivate from time to time, often without causing symptoms.

Requirements

Male or Female
Healthy
18 - 25 years old
BMI 18 - 40 kg/m²
Not taking any medications
Non-smoker, Occasional smoker or Heavy smoker

Study visits

Appointment only, 1 clinic visit

Remuneration

Up to $200

1 clinic visit

Learn more about the Explore Study Apply

3 steps to get started

Step 1

Explore our current trials and complete a short eligibility form. This helps us understand if you meet the basic criteria for one of our upcoming studies.

Step 2

Speak with our team

You can either call us directly or schedule a time that works for you. We’ll arrange a conversation with our recruitment team to confirm your eligibility, answer any questions, and match you with a suitable study.

Step 3

Screening appointment

Visit the clinic for a free health check. You’ll meet with a medical officer to review your medical history, complete a physical exam, and go through the informed consent process. If you pass screening and eligibility, you’ll be booked into the trial.

Check your eligibility